Related Experiment Video
Updated: Jun 11, 2025

Isolation and Propagation of Circulating Tumor Cells from a Mouse Cancer Model
Published on: October 9, 2015
Perspectives of an NCI T32 Training Program Designed to Train a Diverse Workforce in Cancer Health Equity Research
Mackenzie A Ferguson1,2,3, Lisa Tussing Humphreys4,5, Ifeanyi Beverly Chukwudozie4
1Department of Pediatrics, University of Illinois Chicago, Chicago, IL, USA. mfergu9@uic.edu.
Abstract:
With cancer health disparities on the rise in the United States (USA), there is an increased need for novel approaches to address these challenges. One such approach that may help address these disparities is increasing diversity in the biomedical research workforce. The Cancer Health Equity and Career Development Program (CHECDP) embodies this approach by recruiting and training underrepresented minorities in cancer research to develop the skills and training needed to be competitive for independent research careers, thus diversifying the biomedical research workforce. The training model that CHECDP employs is unique with its funding through the NCI training mechanism, its strong institutional support, and its participant-driven curriculum. The curriculum includes educational, career, and leadership opportunities that are continuously evaluated for sustained impact. The program has been comprised of mostly under-represented minorities that have been propelled to independent careers with a high rate of funded career development awards. Our T32 program serves as a model of success for other programs seeking to diversify the biomedical research workforce and reduce cancer health disparities.
Related Concept Videos
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Cancer Survival Analysis
Ethical Issues
Ethical Concerns in Healthcare:
Targeted Cancer Therapies
There are several types of targeted therapies against...
Longitudinal Research
Tumor Immunotherapy

